Captain & Commander go on a road trip for Famotidine
Camber Pharma Launches Generic Pepcid®
Famotidine Tablets are indicated in adult and pediatric patients 88lb and greater for the treatment of:
– active duodenal ulcer (DU)
– active gastric ulcer (GU)
– symptomatic nonerosive gastroesophageal reflux disease (GERD)
Famotidine Tablets are indicated in adults for the:
– treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias).
– reduction of the risk of duodenal ulcer recurrence
Famotidine Tablets from Camber are available in 20 mg 100 and 1000 count bottles and 40 mg 100, 500 and 1000 count bottles. Click here to learn more about Famotidine.
Recent articles
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year
- Camber Launches Mycophenolate Mofetil Capsules
- Camber Launches Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution
- Camber’s Triple Play – Featured Generics
- Big Game Commercial
- Charting a Bold Path for 2025